As a medium company, your core demands have always been: to create safe, compliant, stable and highly adaptable cell culture medium products that meet both scientific research and industrial production needs, while avoiding raw material risks and controlling production costs. ART101S Recombinant Human Albumin accurately addresses the core pain points of the medium industry, and with its core advantages of animal-free, high purity and high stability, it has become the preferred raw material in medium formulations, helping your products enhance competitiveness and seize market opportunities.

Solving the pain points of medium raw materials, ART101S builds a solid line of defense for safety and compliance. Currently, the medium industry is evolving from the BSA era and the plasma-derived HSA era to a more compliant recombinant human albumin (rHSA) era. Institutions such as CDE, FDA, and EMA all encourage the use of serum-free and xenogeneic-free materials, and the requirements for the safety and compliance of raw materials are constantly increasing[2][3]. ART101S adopts a high-efficiency Pichia pastoris expression system, and through precise genetic recombination and multi-step precision chromatography purification processes, it completely eliminates the risk of contamination by animal-derived components and blood-borne viruses (such as HIV, HBV), eradicates the hidden danger of exogenous factor contamination from the source, and perfectly replaces the heterologous immunogenicity risk of traditional BSA (bovine serum albumin) and the blood source shortage and batch fluctuation problems of HSA (plasma-derived albumin)[2][4]. This allows your medium products to easily meet domestic and foreign compliance approval requirements and reduce the regulatory risks of clinical declaration and commercial production.

Adapting to the core needs of medium, with excellent performance and more advantages. As a key supplement for cell culture medium, ART101S has multiple functions such as nutrient supply, osmotic pressure regulation, pH stabilization, and cell protection, and can be widely adapted to various cell culture medium formulations[1]. Its purity is ≥99.0%, double-verified by SDS-PAGE and Western blotting, with no nuclease or protease residues. The total protein content is controlled between 95.0% and 110.0%, the bacterial endotoxin is <0.005EU/mg, and the pH value is stable between 6.4 and 7.4, with excellent batch-to-batch consistency[4]. It effectively avoids medium performance fluctuations caused by differences in raw material batches, ensures the repeatability of cell culture results, and greatly improves the qualification rate of your medium products. At the same time, ART101S is perfectly compatible with other medium components such as hormones, vitamins, and growth factors. It can adsorb and remove reactive oxygen species generated during cell culture, protect cells from stress damage, and promote the survival and proliferation of various cells such as stem cells, CHO cells, HEK293 cells, and immune cells[1][6]. It is suitable for various scenarios such as serum-free medium, stem cell medium, and industrial-grade cell culture, helping you create differentiated medium products.

Strict quality control, meeting the needs of large-scale medium production. ART101S strictly complies with Tonghua Artet's enterprise standard Q/ART 002-2024, as well as the Chinese Pharmacopoeia 2020 Edition and the USP-NF 2023 Edition international standards. Each batch of products undergoes comprehensive quality inspection and provides a complete COA report, which can trace the source of raw materials and the production process, fully complying with the quality management specifications for raw materials used in the production of cell therapy products[3]. The product is an off-white loose powder or lyophilized powder, easy to dissolve and store. The packaging specifications include 10g/bottle and 100g/bottle, which can be customized according to your medium production scale, supporting small-batch sample testing and large-scale procurement to meet the full-process needs from R&D, pilot test to mass production. Relying on Tonghua Artet's global largest recombinant human albumin production line (with an annual output of up to 50 tons), stable supply can be achieved, completely solving the problem of raw material shortage and ensuring that your production progress is not affected[5].

Brand strength escort, exclusive services adapted to medium companies. As the world's first enterprise to launch recombinant human albumin injection, Tonghua Artet has independently developed core technologies, reducing the glycosylation level of ART101S to less than 3%, and its molecular structure is almost consistent with that of human liver neonatal serum albumin, with performance superior to similar recombinant albumin products[5]. We provide exclusive technical support for medium companies, answering questions related to raw material selection, formula adaptation, and usage methods one-on-one, helping you optimize medium formulas and improve product performance; we adopt cold chain transportation, strictly follow the storage requirements of 2-8℃ protected from light and hermetically sealed, ensuring the stable quality of raw materials during transportation and storage, and the 2-year shelf life can effectively reduce your inventory loss; spot supply is available to quickly respond to your urgent procurement needs, helping you efficiently promote production and R&D.

Choosing ART101S Recombinant Human Albumin means choosing safer, more stable and more compliant medium raw materials, and empowering the core competitiveness of your products. Whether you focus on the R&D and production of scientific research-grade medium, industrial-grade cell culture medium, or stem cell medium, ART101S can accurately adapt to your needs, work with you to solve raw material pain points, promote the high-quality development of the medium industry, and win a new future in the market!

Important Notice